{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:50:21Z","timestamp":1791557421413,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004937","name":"Bundesministerium fur Bildung und Forschung Dienststelle Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FKZ 01K12012"],"award-info":[{"award-number":["FKZ 01K12012"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.tim.2021.09.007","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T02:46:34Z","timestamp":1633747594000},"page":"411-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["RNA-based therapeutics to treat human fungal infections"],"prefix":"10.1016","volume":"30","author":[{"given":"Alexander","family":"Bruch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A.","family":"Kelani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8015-9019","authenticated-orcid":false,"given":"Matthew G.","family":"Blango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2021.09.007_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.chom.2019.06.009","article-title":"Rapid worldwide emergence of pathogenic fungi","volume":"26","author":"Rhodes","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tim.2021.09.007_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00449-20","article-title":"Threats posed by the fungal kingdom to humans, wildlife, and agriculture","volume":"11","author":"Fisher","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.tim.2021.09.007_bb0015","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/CMR.00126-13","article-title":"Cryptococcus gattii infections","volume":"27","author":"Chen","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.tim.2021.09.007_bb0020","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.tim.2021.09.007_bb0025","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00140-18","article-title":"Aspergillus fumigatus and aspergillosis in 2019","volume":"33","author":"Latge","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.tim.2021.09.007_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01588-17","article-title":"Candida auris: an emerging fungal pathogen","volume":"56","author":"Spivak","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.tim.2021.09.007_bb0035","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1038\/s41467-018-07779-6","article-title":"Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species","volume":"9","author":"Munoz","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2021.09.007_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tim.2021.09.007_bb0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/jof6010028","article-title":"Aspiring antifungals: review of current antifungal pipeline developments","volume":"6","author":"Gintjee","year":"2020","journal-title":"J. Fungi (Basel)"},{"key":"10.1016\/j.tim.2021.09.007_bb0050","first-page":"561","article-title":"Overview of treatment options for invasive fungal infections","volume":"49","author":"Pound","year":"2011","journal-title":"Med. Mycol."},{"key":"10.1016\/j.tim.2021.09.007_bb0055","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aap7999","article-title":"Worldwide emergence of resistance to antifungal drugs challenges human health and food security","volume":"360","author":"Fisher","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.tim.2021.09.007_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-41199-1_1","article-title":"Therapeutic potential of small molecules and engineered proteins","volume":"219","author":"Gurevich","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.tim.2021.09.007_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-017-0450-0","article-title":"Advances in the delivery of RNA therapeutics: From concept to clinical reality","volume":"9","author":"Kaczmarek","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.tim.2021.09.007_bb0070","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.tips.2020.08.004","article-title":"Paving the road for RNA therapeutics","volume":"41","author":"Dammes","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tim.2021.09.007_bb0075","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome","volume":"1","author":"Hopkins","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tim.2021.09.007_bb0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrd.2017.252","article-title":"Glimmers in illuminating the druggable genome","volume":"17","author":"Rodgers","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tim.2021.09.007_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107534","article-title":"The challenge and prospect of mRNA therapeutics landscape","volume":"40","author":"Weng","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.tim.2021.09.007_bb0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrg2968","article-title":"Current prospects for RNA interference-based therapies","volume":"12","author":"Davidson","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tim.2021.09.007_bb0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2004.07.007","article-title":"Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs","volume":"15","author":"Meister","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tim.2021.09.007_bb0100","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1073\/pnas.200217597","article-title":"AGO1, QDE-2, and RDE-1 are related proteins required for post-transcriptional gene silencing in plants, quelling in fungi, and RNA interference in animals","volume":"97","author":"Fagard","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2021.09.007_bb0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-pharmtox-010715-103633","article-title":"RNA interference (RNAi)-based therapeutics: delivering on the promise?","volume":"56","author":"Bobbin","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tim.2021.09.007_bb0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mib.2018.02.003","article-title":"Cross-kingdom RNA trafficking and environmental RNAi \u2013 nature's blueprint for modern crop protection strategies","volume":"46","author":"Cai","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.tim.2021.09.007_bb0115","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/pbi.13589","article-title":"Spray-induced gene silencing for disease control is dependent on the efficiency of pathogen RNA uptake","volume":"19","author":"Qiao","year":"2021","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.tim.2021.09.007_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008090","article-title":"Small RNAs and extracellular vesicles: New mechanisms of cross-species communication and innovative tools for disease control","volume":"15","author":"Cai","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2021.09.007_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4155\/tde-2018-0061","article-title":"Developing small activating RNA as a therapeutic: current challenges and promises","volume":"10","author":"Kwok","year":"2019","journal-title":"Therapeut. Deliv."},{"key":"10.1016\/j.tim.2021.09.007_bb0130","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.ymthe.2017.07.018","article-title":"Development and mechanism of small activating RNA targeting CEBPA, a novel therapeutic in clinical trials for liver cancer","volume":"25","author":"Voutila","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tim.2021.09.007_bb0135","doi-asserted-by":"crossref","first-page":"17337","DOI":"10.1073\/pnas.0607015103","article-title":"Small dsRNAs induce transcriptional activation in human cells","volume":"103","author":"Li","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2021.09.007_bb0140","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1186\/1471-2164-14-914","article-title":"Divergent transcription is associated with promoters of transcriptional regulators","volume":"14","author":"Lepoivre","year":"2013","journal-title":"BMC Genom."},{"key":"10.1016\/j.tim.2021.09.007_bb0145","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1158\/1078-0432.CCR-20-0414","article-title":"MTL-CEBPA, a small activating RNA therapeutic upregulating C\/EBP-\u03b1, in patients with advanced liver cancer: a first-in-human, multicenter, open-label, phase I trial","volume":"26","author":"Sarker","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tim.2021.09.007_bb0150","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2174\/1389201019666180611093428","article-title":"Development of MTL-CEBPA: small activating RNA drug for hepatocellular carcinoma","volume":"19","author":"Setten","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.tim.2021.09.007_bb0155","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.tim.2021.09.007_bb0160","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.7150\/thno.25958","article-title":"Aptamers in the therapeutics and diagnostics pipelines","volume":"8","author":"Kaur","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.tim.2021.09.007_bb0165","first-page":"31","article-title":"Commercialization of an aptamer-based diagnostic test","volume":"18","author":"Penner","year":"2012","journal-title":"IVD Technol."},{"key":"10.1016\/j.tim.2021.09.007_bb0170","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3390\/jcm9062004","article-title":"Antisense oligonucleotides: an emerging area in drug discovery and development","volume":"9","author":"Dhuri","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tim.2021.09.007_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119711","article-title":"Ex vivo cell-based CRISPR\/Cas9 genome editing for therapeutic applications","volume":"234","author":"Li","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.tim.2021.09.007_bb0180","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa1817426","article-title":"CRISPR-edited stem cells in a patient with HIV and acute lymphocytic leukemia","volume":"381","author":"Xu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tim.2021.09.007_bb0185","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1073\/pnas.1407473111","article-title":"Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5\u039432 mutation confers resistance to HIV infection","volume":"111","author":"Ye","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2021.09.007_bb0190","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.stemcr.2018.11.006","article-title":"\u03b2 Cell replacement after gene editing of a neonatal diabetes-causing mutation at the insulin locus","volume":"11","author":"Ma","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.tim.2021.09.007_bb0195","doi-asserted-by":"crossref","first-page":"20070","DOI":"10.1038\/srep20070","article-title":"CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients","volume":"6","author":"Su","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tim.2021.09.007_bb0200","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.molmed.2020.08.007","article-title":"RNA therapeutics are stepping out of the maze","volume":"26","author":"Agrawal","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tim.2021.09.007_bb0205","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/d41573-020-00078-0","article-title":"RNA therapeutics on the rise","volume":"19","author":"Wang","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tim.2021.09.007_bb0210","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","volume":"35","author":"Dowdy","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tim.2021.09.007_bb0215","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1128\/EC.00355-07","article-title":"RNA silencing gene truncation in the filamentous fungus Aspergillus nidulans","volume":"7","author":"Hammond","year":"2008","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.tim.2021.09.007_bb0220","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1209575","article-title":"Compatibility with killer explains the rise of RNAi-deficient fungi","volume":"333","author":"Drinnenberg","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tim.2021.09.007_bb0225","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1073\/pnas.1118859109","article-title":"Candida albicans Dicer (CaDcr1) is required for efficient ribosomal and spliceosomal RNA maturation","volume":"109","author":"Bernstein","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2021.09.007_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005868","article-title":"Gene network polymorphism illuminates loss and retention of novel RNAi silencing components in the cryptococcus pathogenic species complex","volume":"12","author":"Feretzaki","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tim.2021.09.007_bb0235","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1093\/nar\/gkab238","article-title":"A ribonuclease III involved in virulence of Mucorales fungi has evolved to cut exclusively single-stranded RNA","volume":"49","author":"Canovas-Marquez","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tim.2021.09.007_bb0240","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.molcel.2010.04.005","article-title":"Diverse pathways generate microRNA-like RNAs and Dicer-independent small interfering RNAs in fungi","volume":"38","author":"Lee","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tim.2021.09.007_bb0245","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nature13575","article-title":"Antifungal drug resistance evoked via RNAi-dependent epimutations","volume":"513","author":"Calo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tim.2021.09.007_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005692","article-title":"The lncRNA RZE1 controls cryptococcal morphological transition","volume":"11","author":"Chacko","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tim.2021.09.007_bb0255","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4161\/rna.6.2.7717","article-title":"Development-dependent scavenging of nucleic acids in the filamentous fungus Aspergillus fumigatus","volume":"6","author":"Jochl","year":"2009","journal-title":"RNA Biol."},{"key":"10.1016\/j.tim.2021.09.007_bb0260","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Kariko","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2021.09.007_bb0265","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tim.2021.09.007_bb0270","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/mt.2012.7","article-title":"Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin","volume":"20","author":"Kariko","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tim.2021.09.007_bb0275","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1093\/nar\/gkq347","article-title":"Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation","volume":"38","author":"Anderson","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tim.2021.09.007_bb0280","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6893","article-title":"Impact of mRNA chemistry and manufacturing process on innate immune activation","volume":"6","author":"Nelson","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tim.2021.09.007_bb0285","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01938-16","article-title":"Inhibition of Pseudomonas aeruginosa by peptide-conjugated phosphorodiamidate morpholino oligomers","volume":"61","author":"Howard","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2021.09.007_bb0290","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02411-20","article-title":"Peptide-conjugated phosphorodiamidate morpholino oligomers retain activity against multidrug-resistant Pseudomonas aeruginosa in vitro and in vivo","volume":"12","author":"Moustafa","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.tim.2021.09.007_bb0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41578-020-00277-6","article-title":"Extracellular vesicles versus synthetic nanoparticles for drug delivery","volume":"6","author":"Witwer","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.tim.2021.09.007_bb0300","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1073\/pnas.1213755110","article-title":"Extracellular transmission of a DNA mycovirus and its use as a natural fungicide","volume":"110","author":"Yu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2021.09.007_bb0305","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.devcel.2020.11.007","article-title":"Programmable extracellular vesicles for macromolecule delivery and genome modifications","author":"Zhang","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.tim.2021.09.007_bb0310","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00596-20","article-title":"Human neutrophils produce antifungal extracellular vesicles against Aspergillus fumigatus","volume":"11","author":"Shopova","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.tim.2021.09.007_bb0315","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1038\/s41467-020-16241-5","article-title":"Immune modulation by complement receptor 3-dependent human monocyte TGF-beta1-transporting vesicles","volume":"11","author":"Halder","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2021.09.007_bb0320","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00279-21","article-title":"Cryptococcus neoformans \u2013 infected macrophages release proinflammatory extracellular vesicles: insight into their components by multi-omics","volume":"12","author":"Zhang","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.tim.2021.09.007_bb0325","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019711","article-title":"Fungal vaccines and immunotherapeutics","volume":"4","author":"Santos","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.tim.2021.09.007_bb0330","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biopha.2018.10.075","article-title":"Fungal vaccines, mechanism of actions and immunology: A comprehensive review","volume":"109","author":"Nami","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tim.2021.09.007_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.608460","article-title":"RNA vaccines: a suitable platform for tackling emerging pandemics?","volume":"11","author":"Sandbrink","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2021.09.007_bb0340","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.1074\/jbc.R115.708842","article-title":"Extracellular RNAs: a secret arm of immune system regulation","volume":"291","author":"de Candia","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tim.2021.09.007_bb0345","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41589-018-0142-0","article-title":"Small molecules that target group II introns are potent antifungal agents","volume":"14","author":"Fedorova","year":"2018","journal-title":"Nat. Chem. Biol."}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X21002183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X21002183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:46:11Z","timestamp":1760813171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X21002183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0966842X21002183"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2021.09.007","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA-based therapeutics to treat human fungal infections","name":"articletitle","label":"Article Title"},{"value":"Trends in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tim.2021.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}